
|Articles|April 26, 2004
Vigamox gets FDA approval for a supplemental list of susceptible pathogens
Fort Lauderdale-The FDA has approved a supplemental list of susceptiblepathogens to the in vitro labeling of Vigamox ophthalmic solution, AlconLaboratories announced Monday.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Regeneron's EYLEA HD injection 8 mg approved by FDA for the treatment of macular edema following RVO
2
Precise Bio completes procedure using PB-001, a 3D-bioprinted corneal implant
3
EyePoint receives second consecutive positive recommendation from DSMC
4
Defining Retinal Vascular Diseases AMD, DME, RVO
5


















































.png)


